Not Yet Recruiting
SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma
NCT07668570
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified